Start with the name
What is actually being offered?
The ingredient name matters. Write it down, and note whether the product is a shot, a tablet or something else. A label that only says “sleep peptide” leaves an important question unanswered.
A peptide is a short chain of protein building blocks.
As of September 2026, US law did not define what treatment “peptide therapy” meant.
That name alone did not tell you whether a product was legal.
It also does not tell you which medicine you would get. Ask for the exact product name.
What is known
A medicine reviewed for a named use
FDA approval tells you that a particular medicine and its intended use have been reviewed by the US Food and Drug Administration.
Request the product’s full name, along with the use covered by that review.
Where it comes from
FDA explanation of approvalWhat is known
A medicine made to order
A medicine prepared to order by a pharmacy or doctor is called a compounded medicine.
Compounded medicines had no FDA approval in September 2026.
Before these medicines are offered, the FDA does not review their quality, benefits or harms.
When an approved product cannot meet a medical need, compounding can fill that gap.
Where it comes from
FDA compounding explanationIn everyday words Ask what the medicine is, who makes it, and why that particular product is being proposed.
What is known
A product carrying a research label
In 2026, the FDA told peptide sellers that a research label did not make an unapproved drug legal to offer for human use.
Those letters described what the FDA said named sellers had done wrong; they were not court decisions.
Where it comes from
If an offer says “research use only”, ask for the reason it is being proposed as a medicine for you.
FDA explanation of research labelsLook behind the claim
What supports a claim about sleep?
Ask for evidence about the same substance and the same sleep problem. Ask what changed for the people studied, and what did not.
A useful conversation starts with “What sleep problem are we trying to treat?” Then ask “Which study supports this treatment for that problem?”
What is known
When the offer mentions DSIP
DSIP is another name for the substance emideltide. A raw ingredient is a substance used to make a medicine.
As of September 2026, DSIP failed the ingredient rules for pharmacies preparing a medicine on prescription for a named patient.
Those pharmacies could not legally make a medicine from raw DSIP under those rules.
By September 2026, the groups that asked the FDA to allow emideltide (DSIP) in made-to-order medicines had taken back their requests.
Taking back those requests did not give pharmacies permission to make DSIP from raw ingredients.
In July 2026, FDA staff proposed leaving emideltide (DSIP) off the list of raw ingredients these pharmacies may use.
On 23 and 24 July 2026, a committee that advises the FDA met to discuss which raw ingredients these pharmacies could use.
FDA's meeting page still gives no roll-call record and has neither minutes nor a transcript, though HHS's October 30, 2026 draft reports votes in favor of adding six other peptides. Leaving emideltide out does not tell us how the advisers voted on it.
The staff proposal is different from the committee’s advice. If DSIP is offered, ask the pharmacy which rules it uses and how the product meets them today.
In everyday words DSIP is a name for a substance. Ask for the study behind the sleep claim as well as the reason the product may be prescribed.
What is known
An approval tied to a particular sleep condition
As of September 2026, tirzepatide (Zepbound) had FDA approval to treat adults who have obesity and obstructive sleep apnea that is moderate to severe.
Obstructive sleep apnea is a condition in which breathing is blocked during sleep. Obesity is a diagnosis related to body weight.
Ask whether the diagnosis and the proposed medicine match that approval. A general wish to sleep better is not the named use described here.
Where it comes from
FDA sleep-apnea approvalKeep the evidence question specific
Ask whether the study tested the same product, in people with the same problem. Ask about the benefits, the unwanted effects, and the limits of the findings.
If the answer stays vague, keep the question open.
Choose a setting, then check it
What does getting care involve?
Start with a conversation about the sleep problem. A clinician is a doctor or another health professional who treats patients. You can meet in person or use telehealth: a visit by screen, phone or a form.
What is known
Checking the sleep problem still matters
The Federation of State Medical Boards is made up of state boards that issue doctors’ licences.
It advises using the same standard for online care and care given in person.
Its May 2026 guidance rejects prescribing based only on choosing a treatment from a menu.
That guidance also calls for a way for patients to raise their own follow-up questions.
If an examination or test is needed, the group advises the clinician to arrange that care or send the patient to another professional who can provide it.
Where it comes from
This is guidance for state boards. Each state’s own rules govern care there.
Medical-board guidance (PDF) Guidance on checking problems online (PDF)In everyday words A visit is a chance to explain the problem and ask questions. Ask how the service handles a concern that cannot be checked from a distance.
How to check a care offer
Get the names
Get the clinician’s full name, plus the name of the pharmacy that would prepare or send your medicine.
Look up the records
Find the doctor’s record through the state medical board, and check the pharmacy through the state pharmacy board.
Ask how the problem will be checked
Ask how the clinician will look into the sleep problem, answer your questions, and arrange any needed examination or tests.
What is known
Check the doctor and the pharmacy separately
As of September 2026, the doctor needed a licence or medical-board permission from the state the patient was in at the time of the online visit.
If the doctor says a special permission applies, ask what it is called. Ask that state’s medical board whether this permission applies to your visit.
State medical boards publish records of doctors’ licences, along with public records of penalties or other action against doctors.
Seeing no public action in a doctor’s record does not tell you how good that doctor’s care is.
The FDA advises looking for an online pharmacy in your state pharmacy board’s list of licensed pharmacies.
Open “FDA pharmacy licence search” below. Choose your state, then look for the pharmacy’s name.
If the online pharmacy is missing from that list, the FDA advises against using it.
A pharmacy licence alone does not show that the pharmacy is giving out medicines properly.
Get the total in writing
What will the care cost?
The search phrase does not come with a reliable price tag. Request a written quote for the exact medicine and care plan. Compare the amount due now with the ongoing charge.
| Item | Question to ask |
|---|---|
| The visit | What must I pay for the visit, even if no medicine is prescribed? |
| The medicine | What is the full product name, and is its charge separate? |
| Tests and delivery | Which charges are included, and which are added? |
| Later care | What do follow-up visits and ongoing membership cost? |
| Leaving the plan | What must I pay before starting? If I cancel, what will I owe, and what money can I get back? |
Ask what happens to an introductory price. Ask whether a membership continues when the medicine stops. Leave any unanswered charge on the list.
What is known
A coverage question for diagnosed sleep apnea
Medicare drug plans could cover tirzepatide (Zepbound) for its approved sleep-apnea use as of September 2026.
Payment still depended on whether the plan listed the medicine for coverage and agreed to pay under its own rules.
FDA approval did not require an insurance plan to pay for the medicine.
Ask your plan if it needs to approve payment before the pharmacy sends the medicine.
In everyday words Ask the insurer about the exact medicine and the diagnosis on the prescription. Ask what you would pay if the plan agrees to cover it.
This possible route to payment does not establish a price for DSIP or another product advertised for sleep.
Pause over unclear answers
What deserves a pause or urgent help?
Keep the product name, the pharmacy name and the prescription question in view. If an offer leaves them unclear, pause the decision and ask for an explanation.
What is known
A prescription is part of the check
Federal law in September 2026 required a valid prescription for a prescription medicine.
In the rules checked in September 2026, FDA registration meant recording a business with the FDA, not approving it.
Listing a drug with the FDA also did not mean the FDA had approved that medicine.
If a seller says “FDA registered”, ask about FDA approval of the specific medicine for the proposed use.
What is known
Why the source of an injection matters
In letters reviewed in September 2026, the FDA warned sellers that shots can go past the body’s defences against germs and poisons.
Poor compounding can leave germs or other unwanted material in a medicine.
Poor compounding can also leave a medicine with too much or too little of its active ingredient, the ingredient that makes the medicine work.
Ask the clinician and pharmacist how concerns about the product will be handled.
In everyday words Keep the clinician’s and pharmacy’s contact details with the care plan. Ask who can help with a concern between visits.
What is known
Report a medicine problem
Patients can report medicine problems through MedWatch, a service run by the FDA.
Where it comes from
FDA MedWatch informationCarry the questions with you
What can I ask at a visit?
Leave with clear names, reasons and next steps. These questions can keep the conversation on the sleep problem that brought you there.
About the sleep problem
- What sleep problem are we trying to treat?
- What supports this exact medicine for that problem?
- What other approaches can we discuss?
About the product
- Which product is proposed, and why?
- Who makes it, and who sends it?
- What reasons would lead you to rule out prescribing this medicine?
About the plan
- What change are we looking for?
- How will we decide whether to continue?
- Who can I reach with concerns between visits?
A useful next step is a conversation with room for your questions.
Return to the care checks